RxDoctor Payments DataLook up a doctor →

Jennifer Dobrowolski

Nurse Practitioner · Crown Point, INNPI 1396218608

Payments from drug & device makers

$17,731in general payments, 2019–2025

Across 885 payments — averaging $20.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$2K
  • AbbVie$1K
  • MDD US Operations, LLC$984
  • UCB, Inc.$754
  • EMD Serono, Inc.$669
  • Argenx US, Inc.$657
  • plus $12K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen83$1,613
AbbVie(2 entities)88$1,356
MDD US Operations, LLC51$984
UCB, Inc.53$754
EMD Serono, Inc.29$669
Argenx US, Inc.27$657
AstraZeneca(2 entities)24$632
Neurelis, Inc.23$600
Eisai Inc.15$579
Teva Pharmaceuticals USA, Inc.29$565
Pfizer38$551
Lilly USA, LLC30$527
Bristol Myers Squibb21$493
Sanofi12$401
Amneal Pharmaceuticals LLC19$369
Lundbeck LLC21$364
Neurocrine Biosciences, Inc.18$357
Banner Life Sciences, LLC14$343
Genentech USA, Inc.14$329
Novartis18$325
SK Life Science, Inc.16$305
Johnson & Johnson(2 entities)13$295
Catalyst Pharmaceuticals, Inc.18$292
Acadia Pharmaceuticals Inc18$292
Takeda Pharmaceuticals U.S.A., Inc.14$270
Corium, LLC16$268
Kyowa Kirin, Inc.10$267
Biohaven Pharmaceutical Holding Company Ltd.13$260
Otsuka America Pharmaceutical, Inc.8$254
Acorda Therapeutics, Inc12$253
Jazz Pharmaceuticals Inc.13$233
CSL Behring6$230
Biohaven Pharmaceuticals, Inc.15$214
Impel Pharmaceuticals LLC11$193
Vanda Pharmaceuticals Inc.9$187
Axsome Therapeutics, Inc.2$127
E.r. Squibb & Sons, L.L.C.1$125
Tanabe Pharma America, Inc.6$118
Upsher-smith Laboratories LLC7$116
Sumitomo Pharma America, Inc.6$113
Sunovion Pharmaceuticals Inc.7$112
Cycle Pharmaceuticals Inc5$109
Supernus Pharmaceuticals, Inc.6$98
TG Therapeutics, Inc.5$91
Scilex Pharmaceuticals Inc.3$61
Adamas Pharmaceuticals, Inc.3$61
ANI Pharmaceuticals, Inc.2$58
Livanova USA, Inc.2$45
Stryker2$34
Chiesi USA, Inc.2$30
Almatica Pharma LLC1$27
Amgen1$25
Octapharma USA, Inc.1$24
Boston Scientific1$20
Ipsen Biopharmaceuticals, Inc1$20
Avanir Pharmaceuticals, Inc.1$20
Merz Pharmaceuticals, LLC1$17

How this compares

$17,731 in reported general payments places this provider in the 95th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana →

Medicare billing

Part B allowed, 2024
$54,549
Medicare patients
319
Services billed
716

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Crown Point

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →